Informações glucoreumin

GLUCOREUMIN com posologia, indicações, efeitos colaterais, interações e outras informações. Todas as informações contidas na bula de GLUCOREUMIN têm a intenção de informar e educar, não pretendendo, de forma alguma, substituir as orientações de um profissional médico ou servir como recomendação para qualquer tipo de tratamento. Decisões relacionadas a tratamento de pacientes com GLUCOREUMIN devem ser tomadas por profissionais autorizados, considerando as características de cada paciente.



REFERÊNCIAS BIBLIOGRÁFICAS
1- Matheson AJ, Perry CM. Glucosamine: a review of its use in the management of osteoarthritis. Drugs Aging. 2003;20(14):1041-60.
2- Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysatee. Rheum Dis Clin North Am.1999;25(2):379-95.
3- Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung. 2001;51(9):699-725.
4- Drugdex Drug Evaluations; Glucosamine, Micromedex, 2007.
5- Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163(13):1514-22.
6- Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3- year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162(18):2113-23.
7- Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357(9252):251-6.
8- Vidal y Plana RR, KARZEL K: Glucosamine: its importance for the metabolism of articular cartilage. 2. Studies on articular cartilage. Fortschr Med. 1980 Jun 5;98(21):801-6. German.
9- Reichelt A, Forster KK, & Fischer M: Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee: a randomised, placebo- controlled, double-blind study. Arzneimittelforschung 1994; 44:75-80.
10- RTECS: Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2001; provided by Thomson Healthcare Inc., Greenwood Village, CO.
11- S Fabro: The Reproductive Toxicology Center (eds): REPROTOX (electronic version). Georgetown University Medical Center and Reproductive Toxicology Center, Columbia Hospital for Women Medical Center. Washington, DC (Internet Version). Edition expires Feb/28/1999; provided by Thomson Healthcare Inc., Greenwood Village, CO.
12- Tapadinhas MJ, Rivera IC, & Bignamini AA: Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal. Pharmatherapeutica 1982; 3:157-168.
13- Setnikar I et al. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43(10):1109-
14- Drugdex Drug Evaluations, Glucosamine; Micromedex, 2007.